- Home
- CUE vs AGFY Comparison
CUE vs AGFY Comparison
Compare CUE & AGFY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CUE
- AGFY
- Stock Information
- Founded
- CUE 2014
- AGFY 2016
- Country
- CUE United States
- AGFY United States
- Employees
- CUE N/A
- AGFY N/A
- Industry
- CUE Biotechnology: Pharmaceutical Preparations
- AGFY Military/Government/Technical
- Sector
- CUE Health Care
- AGFY Consumer Discretionary
- Exchange
- CUE Nasdaq
- AGFY Nasdaq
- Market Cap
- CUE 48.0M
- AGFY 50.6M
- IPO Year
- CUE 2018
- AGFY 2021
- Fundamental
- Price
- CUE $0.70
- AGFY $22.66
- Analyst Decision
- CUE Strong Buy
- AGFY
- Analyst Count
- CUE 3
- AGFY 0
- Target Price
- CUE $3.00
- AGFY N/A
- AVG Volume (30 Days)
- CUE 220.4K
- AGFY 25.9K
- Earning Date
- CUE 08-13-2025
- AGFY 08-13-2025
- Dividend Yield
- CUE N/A
- AGFY N/A
- EPS Growth
- CUE N/A
- AGFY N/A
- EPS
- CUE N/A
- AGFY N/A
- Revenue
- CUE $7,991,000.00
- AGFY $10,218,000.00
- Revenue This Year
- CUE N/A
- AGFY N/A
- Revenue Next Year
- CUE $23.84
- AGFY N/A
- P/E Ratio
- CUE N/A
- AGFY N/A
- Revenue Growth
- CUE 13.83
- AGFY 9.42
- 52 Week Low
- CUE $0.45
- AGFY $2.71
- 52 Week High
- CUE $1.99
- AGFY $84.44
- Technical
- Relative Strength Index (RSI)
- CUE 55.84
- AGFY 44.51
- Support Level
- CUE $0.54
- AGFY $22.00
- Resistance Level
- CUE $0.66
- AGFY $28.85
- Average True Range (ATR)
- CUE 0.06
- AGFY 2.74
- MACD
- CUE 0.01
- AGFY -0.67
- Stochastic Oscillator
- CUE 81.98
- AGFY 15.78
About CUE Cue Biopharma Inc.
Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its objective is to provide patients suffering from cancer and autoimmune diseases with dramatically improved therapeutic outcomes through the platform of biologic drug product candidates. The other products under pipeline are CUE-101 as a Monotherapy, CUE-101 + Pembrolizumab, CUE-102, CUE-103, and others.
About AGFY Agrify Corporation
Agrify Corp is a developer of branded inventive solutions for the cannabis and hemp industries. Its Senorita brand offers consumers hemp-derived tetrahydrocannabinol (THC) beverages that mirror cocktails like a margarita - in three flavors - classic Lime Jalapeno Margarita, Mango Margarita, and Paloma. In addition to beverages, Agrify has also historically been a provider of inventive cultivation and extraction solutions for the cannabis industry. Its comprehensive extraction product line, which includes hydrocarbon, alcohol, solventless, post-processing, and lab equipment, empowers producers to maximize the quantity and quality of extract required for premium concentrates.